These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

469 related items for PubMed ID: 15542757

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Neuromodulatory role of the endocannabinoid signaling system in alcoholism: an overview.
    Basavarajappa BS, Hungund BL.
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):287-99. PubMed ID: 12052043
    [Abstract] [Full Text] [Related]

  • 3. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR, Egertová M.
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar 29; 356(1407):381-408. PubMed ID: 11316486
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The cannabinoid system and immune modulation.
    Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, Friedman H.
    J Leukoc Biol; 2003 Oct 29; 74(4):486-96. PubMed ID: 12960289
    [Abstract] [Full Text] [Related]

  • 6. Role of the endocannabinoid system in the development of tolerance to alcohol.
    Basavarajappa BS, Hungund BL.
    Alcohol Alcohol; 2005 Oct 29; 40(1):15-24. PubMed ID: 15550443
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Endocannabinoid lipids and mediated system: implications for alcoholism and neuropsychiatric disorders.
    Vinod KY, Hungund BL.
    Life Sci; 2005 Aug 19; 77(14):1569-83. PubMed ID: 16005471
    [Abstract] [Full Text] [Related]

  • 10. The endocannabinoid system and the treatment of obesity.
    Pagotto U, Vicennati V, Pasquali R.
    Ann Med; 2005 Aug 19; 37(4):270-5. PubMed ID: 16019725
    [Abstract] [Full Text] [Related]

  • 11. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
    Martin BR.
    Life Sci; 2005 Aug 19; 77(14):1543-58. PubMed ID: 15949820
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The pharmacology of cannabinoid receptors and their ligands: an overview.
    Pertwee RG.
    Int J Obes (Lond); 2006 Apr 19; 30 Suppl 1():S13-8. PubMed ID: 16570099
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.
    Petrosino S, Di Marzo V.
    Curr Opin Investig Drugs; 2010 Jan 19; 11(1):51-62. PubMed ID: 20047159
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.
    Patel S, Hillard CJ.
    J Pharmacol Exp Ther; 2006 Jul 19; 318(1):304-11. PubMed ID: 16569753
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways.
    Sterin-Borda L, Del Zar CF, Borda E.
    Biochem Pharmacol; 2005 Jun 15; 69(12):1705-13. PubMed ID: 15885656
    [Abstract] [Full Text] [Related]

  • 19. The endocannabinoid-CB(1) receptor system in pre- and postnatal life.
    Fride E.
    Eur J Pharmacol; 2004 Oct 01; 500(1-3):289-97. PubMed ID: 15464041
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.